Analysis – Page 12 – Goldea Capital

Ignitis Group updates Euro Medium Term Note Programme

Written by Customer Service on September 3, 2026. Posted in Public Companies.

AB “Ignitis grupė” (hereinafter – the Group) informs that on 3 September 2026 its Management Board decided to update the Group’s up to EUR 2,000,000,000 Euro Medium Term Note Programme (hereinafter – the Programme) and approved the base prospectus of the Programme (hereinafter – the Base Prospectus) (attached). The Programme provides a framework for future debt issuances in the international capital markets. The updated Base Prospectus has been approved by the Luxembourg Commission de Surveillance du Secteur Financier (CSSF). The Programme update follows the recent publication of the Group’s updated Green Finance Framework and the launch of its European Green Bond Factsheet (link). The Group has two investment-grade credit ratings: BBB+ with a Stable outlook assigned by S&P Global Ratings and Baa1 with a Stable outlook...

Ignitis Group updates Euro Medium Term Note Programme

Written by Customer Service on September 3, 2026. Posted in Public Companies.

Inside information: Kalmar plans to simplify its operating model to accelerate growth, enhance customer focus, and optimize operational efficiency

Written by Customer Service on September 3, 2026. Posted in Public Companies.

KALMAR CORPORATION, STOCK EXCHANGE RELEASE (INSIDE INFORMATION), SEPTEMBER 3, 2026 AT 17:00 EEST / 16:00 CEST Inside information: Kalmar plans to simplify its operating model to accelerate growth, enhance customer focus, and optimize operational efficiency The Board of Directors of Kalmar Corporation has decided to initiate a planning and reorganization of its operating model to accelerate growth, enhance customer focus, and drive efficiency. As one crucial step, Kalmar plans to combine its Terminal Tractors and Horizontal Transportation divisions into a single, unified division. This strategic move is designed to simplify and bring more clarity to our governance, accelerate development, and enhance R&D across both port and terminals and distribution end-customer segments. This step of the planned operating model renewal represents...

Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of August 31, 2026

Written by Customer Service on September 3, 2026. Posted in Public Companies.

Press ReleaseVELIZY-VILLACOUBLAY, France — September 3, 2026 Declaration of the number of outstanding shares and voting rights as of August 31, 2026 Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced below the total number of its outstanding shares and voting rights as of August 31, 2026, according to articles 223-16 and 221-3 of the General Regulation of the Autorité des marchés financiers. Number of outstanding shares: 1,342,915,029 Number of voting rights*: 2,018,713,316 *The total number of voting rights is calculated on the basis of the total number of outstanding shares, even if the voting rights attached thereto are suspended, pursuant to Article 223-11 of the General Regulation of the Autorité des marchés financiers relating to the method for calculating the percentages of holdings in shares...

Correction: Notifications on transactions concluded by managers of the companies

Written by Customer Service on September 3, 2026. Posted in Public Companies.

It is clarified that the previously published information regarding the transactions made by the manager of the company on 26–27 March 2026 contained incorrect information. A total of 729 shares were acquired, instead of the previously reported 2,100 shares. No transactions were made on 30 March 2026, instead of the previously reported acquisition of 1,000 shares. Information on the transactions made is provided in the attachments. Vilija Milaseviciute Economics and finance directorPhone: +370 441 55 102 Email: vilija.milaseviciute@vilvi.euAttachments2026-03-27 Notifications on transactions concluded by managers2026-03-26 Notifications on transactions concluded by managers

New Fluke Engineering Lab at Washington State University Opens to Prepare the Next Generation of Engineers

Written by Customer Service on September 3, 2026. Posted in Public Companies.

New Fluke Engineering Lab to Give More Than 4,000 Students Across Five WSU Campuses Hands-On Experience with Fluke Measurement and Test TechnologyNew Fluke Engineering Lab at Washington State University Opens to Prepare the Next Generation of EngineersWSU and Fluke are building the next generation of engineers – 4,000+ students, five campuses, hands-on experience.New Fluke Engineering Lab at Washington State University Opens to Prepare the Next Generation of EngineersWSU and Fluke are building the next generation of engineers – 4,000+ students, five campuses, hands-on experience.Everett, Washington, Sept. 03, 2026 (GLOBE NEWSWIRE) — U.S. manufacturing could need as many as 3.8 million new workers by 2033, with up to 1.9 million jobs potentially going unfilled because of skills and talent gaps.* Bridging...

Cosmos Health: A Company Transformed — 2026 Year-to-Date

Written by Customer Service on September 3, 2026. Posted in Earnings Releases And Operating Results.

Record Revenue Across All Quarters Reported. Balance Sheet Deleveraged. Capital Structure Streamlined. Proprietary IP Filed in Four Global Markets. U.S. Market Entered. Global rollout of proprietary brands continues. Share repurchases underway. Reaffirms Guidance Targets A Comprehensive Corporate Summary — January 1, 2026 through August 31, 2026Revenue record set three consecutive quarters: FY2025 $65.3M (+20%) → Q1 2026 $17.93M (+31%) → Q2 2026 $18.99M (+28.8%) → H1 2026 $36.91M (+29.7%). Annualized adjusted run-rate exceeds $75M. Full-year 2026 guidance: $90M+. ATW $8M convertible note retired 12 months early: No further conversions, no dilution. Strengthened balance sheet: H1 2026 total liabilities reduced 13.3% and stockholders’ equity increased 12.2% Simplified capital structure: No shelf registration, no ATM, no floorless warrants. 5.1M+...

EXEL Industries: Total number of voting rights and shares at 08.31.2026

Written by Customer Service on September 3, 2026. Posted in Public Companies.

EXEL IndustriesA French Société Anonyme with a share capital of €16,969,750Registered office: 54, rue Marcel Paul – 51206 Epernay Cedex – FranceReims Companies Register (RCS): No. 095 550 356 Number of shares and voting rights Article 223-16 of the AMF regulationDate Total number of shares comprising the share capital Total number of voting rightsAugust 31, 2026 6,787,900 Theoretical voting rights: 9,897,118Exercisable voting rights*: 9,890,549 * After deduction of shares without voting rightsAttachmentEXEL Industries Droits de vote 2026.08.31_EN

Final Opportunity to Own a New Luxury Home in Toll Brothers at Tesoro Highlands – Alta Monte Collection in Valencia, California

Written by Customer Service on September 3, 2026. Posted in Public Companies.

VALENCIA, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the final opportunity to purchase a new home in Toll Brothers at Tesoro Highlands – Alta Monte Collection, a gated luxury community in Valencia, California. Only one home remains available for sale in the Alta Monte Collection of the community, located at 29924 North Camino Los Robles Lane in Santa Clarita.A stunning move-in ready Arpina home design, featuring 4,700+ square feet of living space, is available for sale in the community. Showcasing the ultimate luxury living, this home features expansive living spaces and modern finishes. This final home in the Alta Monte Collection is priced from $1.9 million.“This is the final chance for home shoppers to purchase a...

Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States

Written by Customer Service on September 3, 2026. Posted in Public Companies.

Everest Medicines to Lead Commercialization in Greater China, Bringing Novel Innovation to Estimated 3-6 Million Chinese Patients with PSVT Approval Triggers $2.0 Million Payment to Milestone Pharmaceuticals MONTREAL and CHARLOTTE, N.C., Sept. 03, 2026 (GLOBE NEWSWIRE) — Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that China’s National Medical Products Administration (NMPA) has approved etripamil nasal spray for the treatment of paroxysmal supraventricular tachycardia (PSVT) in adults. Etripamil, marketed in the United States as CARDAMYST® nasal spray, is a self-administered treatment for adults with PSVT. The NMPA decision marks the first regulatory approval of etripamil outside the United States...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals